Application of proteomics to cerebrovascular disease - PubMed (original) (raw)
Review
Application of proteomics to cerebrovascular disease
Mingming Ning et al. Electrophoresis. 2012 Dec.
Abstract
While neurovascular diseases such as ischemic and hemorrhagic stroke are the leading causes of disability in the world, the repertoire of therapeutic interventions has remained remarkably limited. There is a dire need to develop new diagnostic, prognostic, and therapeutic options. The study of proteomics is particularly enticing for cerebrovascular diseases such as stroke, which most likely involve multiple gene interactions resulting in a wide range of clinical phenotypes. Currently, rapidly progressing neuroproteomic techniques have been employed in clinical and translational research to help identify biologically relevant pathways, to understand cerebrovascular pathophysiology, and to develop novel therapeutics and diagnostics. Future integration of proteomic with genomic, transcriptomic, and metabolomic studies will add new perspectives to better understand the complexities of neurovascular injury. Here, we review cerebrovascular proteomics research in both preclinical (animal, cell culture) and clinical (blood, urine, cerebrospinal fluid, microdialyates, tissue) studies. We will also discuss the rewards, challenges, and future directions for the application of proteomics technology to the study of various disease phenotypes. To capture the dynamic range of cerebrovascular injury and repair with a translational targeted and discovery approach, we emphasize the importance of complementing innovative proteomic technology with existing molecular biology models in preclinical studies, and the need to advance pharmacoproteomics to directly probe clinical physiology and gauge therapeutic efficacy at the bedside.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Conflict of interest statement
The authors have declared no conflict of interest.
Figures
Figure 1
Proteomic methodologies used to study cerebrovascular disease in publications reviewed. Methods were grouped into three categories: (i) Expression Profiling—discovery approach using shotgun MS analysis with in-gel or LC separation; (ii) Comparative/Quantitative Proteomics—semiquantitative isotope labeled and label-free technique for tissue and cell media; (iii) Validation—targeted quantitative approaches measuring specific protein level using antibody based and nonantibody-based methods. DIGE, 2D difference gel electrophoresis; SELDI-TOF, surface-enhanced laser desorption/ionization time-of-flight; SILAC, stable isotope labeling with amino acids in cell culture; C12/13 acrylamide; iTRAQ, isobaric tags for relative and absolute quantification; TMT, tandem mass tags; WB, Western blot; IHC, immunohistochemistry; SRM, selected reaction monitoring; MRM, multiple reaction monitoring.
Similar articles
- Novel pathophysiological markers are revealed by iTRAQ-based quantitative clinical proteomics approach in vascular dementia.
Datta A, Qian J, Chong R, Kalaria RN, Francis P, Lai MK, Chen CP, Sze SK. Datta A, et al. J Proteomics. 2014 Mar 17;99(100):54-67. doi: 10.1016/j.jprot.2014.01.011. Epub 2014 Jan 19. J Proteomics. 2014. PMID: 24448401 Free PMC article. Clinical Trial. - Structural Proteomics: Detection of Neurodegenerative Protein Modifications.
Khurana M, Rahman SO, Agarwal S, Akhtar MS, Aldughaim MS, Pottoo FH, Najmi AK. Khurana M, et al. Curr Protein Pept Sci. 2021 Dec 27;22(9):641-655. doi: 10.2174/1389203722666211029101002. Curr Protein Pept Sci. 2021. PMID: 34719370 Review. - Quantitative clinical proteomic study of autopsied human infarcted brain specimens to elucidate the deregulated pathways in ischemic stroke pathology.
Datta A, Akatsu H, Heese K, Sze SK. Datta A, et al. J Proteomics. 2013 Oct 8;91:556-68. doi: 10.1016/j.jprot.2013.08.017. Epub 2013 Sep 2. J Proteomics. 2013. PMID: 24007662 - Proteomics and Neurodegenerative Disorders: Advancements in the Diagnostic Analysis.
Puranik N, Yadav D, Yadav SK, Chavda VK, Jin JO. Puranik N, et al. Curr Protein Pept Sci. 2020;21(12):1174-1183. doi: 10.2174/1389203721666200511094222. Curr Protein Pept Sci. 2020. PMID: 32392110 Review.
Cited by
- Quantitative Proteomics Reveal Region-Specific Alterations in Neuroserpin-Deficient Mouse Brain and Retina: Insights into Serpini1 Function.
Mirshahvaladi S, Chitranshi N, Amirkhani A, Rajput R, Basavarajappa D, Vander Wall R, Pascovici D, Godinez A, Galliciotti G, Paulo JA, Gupta V, Graham SL, Gupta V, Mirzaei M. Mirshahvaladi S, et al. Proteomes. 2024 Mar 14;12(1):7. doi: 10.3390/proteomes12010007. Proteomes. 2024. PMID: 38535505 Free PMC article. - Potential Protein Signatures for Recurrence Prediction of Ischemic Stroke.
Zhang C, Liu Y, Zhu H, Huang X, Guo C, Cheng S, Yuan M, Jiang Y, Meng X, Johnston SC, Wang Y, Jin WN, Shi FD. Zhang C, et al. J Am Heart Assoc. 2024 Mar 5;13(5):e032840. doi: 10.1161/JAHA.123.032840. Epub 2024 Feb 29. J Am Heart Assoc. 2024. PMID: 38420847 Free PMC article. - Plasma Proteomic Associations With Incident Ischemic Stroke in Older Adults: The Cardiovascular Health Study.
Kalani R, Bartz TM, Psaty BM, Elkind MSV, Floyd JS, Gerszten RE, Shojaie A, Heckbert SR, Bis JC, Austin TR, Tirschwell DL, Delaney JAC, Longstreth WT Jr. Kalani R, et al. Neurology. 2023 May 23;100(21):e2182-e2190. doi: 10.1212/WNL.0000000000207242. Epub 2023 Apr 4. Neurology. 2023. PMID: 37015819 Free PMC article. - Galectin-3 Mediated Inflammatory Response Contributes to Neurological Recovery by QiShenYiQi in Subacute Stroke Model.
Wang Y, He S, Liu X, Li Z, Zhu L, Xiao G, Du X, Du H, Zhang W, Zhang Y, Orgah J, Feng Y, Zhang B, Zhu Y. Wang Y, et al. Front Pharmacol. 2021 Apr 19;12:588587. doi: 10.3389/fphar.2021.588587. eCollection 2021. Front Pharmacol. 2021. PMID: 33953667 Free PMC article. - Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study.
Deng W, Yin S, McMullin D, Inglessis-Azuaje I, Elmariah S, Hung J, Lo EH, Palacios IF, Buonanno FS, Ning M. Deng W, et al. Ann Intern Med. 2020 Jun 2;172(11):717-725. doi: 10.7326/M19-3583. Epub 2020 May 12. Ann Intern Med. 2020. PMID: 32422058 Free PMC article.
References
- Group NINDS. N. Engl. J. Med. 1995;333:1581–1587. - PubMed
- Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG. Stroke. 2001;32:1832–1840. - PubMed
- Morgenstern LB, Bartholomew LK, Grotta JC, Staub L, King M, Chan W. Arch. Intern. Med. 2003;163:2198–2202. - PubMed
- Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Haley EC, Jr, Kwiatkowski T, Levine SR, Lewandowski C, Lu M, Lyden P, Marler JR, Patel S, Tilley BC, Albers G, Bluhmki E, Wilhelm M, Hamilton S. Lancet. 2004;363:768–774. - PubMed
- Hacke W, Kaste M, Bluhmki E, Brozman M, Davalos A, Guidetti D, Larrue V, Lees KR, Medeghri Z, Machnig T, Schneider D, von Kummer R, Wahlgren N, Toni D. N. Engl. J. Med. 2008;359:1317–1329. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 NS076694/NS/NINDS NIH HHS/United States
- R01 NS093415/NS/NINDS NIH HHS/United States
- R01 NS067139/NS/NINDS NIH HHS/United States
- R37 NS037074/NS/NINDS NIH HHS/United States
- P01-NS55104/NS/NINDS NIH HHS/United States
- P01 NS055104/NS/NINDS NIH HHS/United States
- RC2 NS069335/NS/NINDS NIH HHS/United States
LinkOut - more resources
Full Text Sources